Dare Bioscience Inc (NAS:DARE)
$ 3.2711 -0.1 (-2.98%) Market Cap: 27.96 Mil Enterprise Value: 13.07 Mil PE Ratio: 0.21 PB Ratio: 10.45 GF Score: 34/100

Q3 2023 Dare Bioscience Inc Earnings Call Transcript

Nov 09, 2023 / 09:30PM GMT
Release Date Price: $3.95 (-6.93%)
Operator

Welcome to the conference call hosted by Daré Bioscience to review the company's third-quarter financial results and to provide a general business update. This call is being recorded. My name is Chris, and I'll be your operator for today. With us today from Daré are Sabrina Martucci Johnson, President and Chief Executive Officer; John Fair, Chief Commercial Officer; and Lisa Walters-Hoffert, Chief Financial Officer.

Ms. Johnson, please proceed.

Sabrina Johnson
Dare Bioscience Inc - President, Chief Executive Officer, Secretary, Director

Thank you. Good afternoon, and welcome to the Daré Bioscience financial results and business update call for the quarter ended September 30, 2023. Today we will review our third-quarter results and discuss developments and expectations for our pipeline and portfolio.

Before we begin, I'd like to remind you that today's discussion will include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot